Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Post-conditioning and Vitamin C effects on skeletal muscle high energy phosphates
2007-002520-16Phase 2Completed
- Sponsor
- Department of Clinical Pharmacology, Medical University of Vienna
- Start
- May 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of ascorbic acid in ischemia-reperfusion injury (IRI) and peripheral arterial disease (PAD) (2 arms), sponsored by Department of Clinical Pharmacology, Medical University of Vienna. Primary endpoint: Primary. Started May 2007; status: completed.
02
Drugs
ascorbic acid
03
Conditions
ischemia-reperfusion injury (IRI)peripheral arterial disease (PAD)
Beyond the preview
Go deeper on 2007-002520-16.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-002520-16.